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Abstract
The two patients in this case series had experienced long-term difficulty controlling lymphedema at
home. Both patients had used numerous home therapies, including older-generation intermittent
pneumatic compression devices, without success. The Flexitouch® system, an advanced pneumatic
device, was prescribed to assist them with in-home efforts by providing therapy to their affected
limbs in addition to the lower trunk area for the patient with lymphedema of the lower extremity;
and the trunk, chest wall, and shoulder areas for the patient with lymphedema of the upper
extremity. Both patients achieved successful home maintenance of lymphedema, as judged by limb
volume, clinical observations, and subjective patient impressions, after incorporating the Flexitouch®
system. Neither patient experienced the deleterious effects (worsening genital edema; fibrotic cuff
development) that they had experienced with the older-generation intermittent pneumatic
compression devices they had previously used. Incorporating the Flexitouch® system as part of
maintenance may improve success for lymphedema patients who have previously struggled with in-
home management.
Introduction
Methods for the home management of lymphedema
include self-manual lymphatic drainage (MLD) [1,2], but
some patients are not able to perform self-MLD successfully
at home due to limited mobility [3], inability to execute the
techniques properly, or lack of caregiver assistance. Use of
repeated cycles of intensive complete decongestive therapy
(CDT) is not a practical long-term solution and is often not
covered by insurance [3]. Patients become frustrated with
the inadequacy of efforts to control lymphedema [4]. The
condition is associated with an adverse psychological
impact and impairments in quality of life [3,5].
As a therapist, I eventually became frustrated by barriers to
successful home care and began to seek options to improve
my patients’ likelihood of success. One option to assist in
the self-MLD portion of home care for lymphedema is the
use of an intermittent pneumatic compression (IPC)
device. The National Lymphedema Network Position
Statement and the International Society of Lymphology
identify IPC as an adjunct to lymphedema therapy, but
caution that its use may lead to complications [2,6].
I do not typically recommend compression pumps for
lymphedema patients because of negative patient
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experiences with older-generation pumps. However, an
advanced device is now available that is designed to
overcome the therapeutic barriers of traditional IPC
devices. The Flexitouch® (FT) system (Tactile Systems
Technology, Inc, Minneapolis, MN) is a pneumatic device
for home maintenance lymphedema therapy [7].
Two cases are presented of patients who had experienced
long-term difficulty controlling lymphedema at home.
They had previously used traditional IPC without success.
The FT system was prescribed to assist in self-care by
providing limb treatment in addition to treatment of the
lower trunk area for the patient with lower-extremity
lymphedema and the chest wall, trunk, and shoulder areas
for the patient with upper-extremity lymphedema.
Both patients had required multiple rounds of CDT at
different clinics and suffered complications secondary to
older-generation pump use prior to presentation at this
clinic.
Patients were interviewed about their experiences with
older-generation IPC devices and the FT system. In
addition, each patient returned to the clinic for two
sessions that were approximately one week apart. Mea-
surements of the affected limb were taken with a Juzo®
tape measure (Juzo, Cuyahoga Falls, OH) before and
immediately after treatment with the FT system at one visit
and again after treatment with the IPC devices they had
previously used at the next. Total limb volumes were
calculated from the measurements.
Case Presentation
Case report 1
The first patient (PT1) was diagnosed in March 2002 with
bilateral (left greater than right) lower extremity and
genital lymphedema (Figure 1A) secondary to vulvar
cancer. A white female non-smoker, when first seen at the
clinic she was 75 years old, 222 lbs in weight and 5’1” in
height. Her cancer treatment included hysterectomy and
excision of 19 inguinal nodes. In 1993, she had a right
total knee replacement for arthritis. Her lymphedema
treatment began in North Carolina in April 2002. From
that time until December 2005, she applied bilateral
bandages and used a non-programmable Extremity
Pump® System 7500 (Kinetic Concepts, Inc, San Antonio,
TX; HCPC code E0651; previously known as the Jobst
pump) for lymphedema in her left lower extremity. After
three years, she discontinued using the device due to
worsening genital edema, lack of efficacy, and difficulty
donning the appliances. She reported that the device
created increased pressure on the legs and aggravated
discomfort at the groin, stating that the device was “too
strong” and that it “hurt”.
In October 2006, she relocated to Georgia and began
treatment at Gwinnett Medical Center for increased pain,
decreased range of motion, cellulitis, and fibrosis. She
received intensive CDT and HydroTrackTM (Conray, Inc,
Phoenix, AZ) therapy, but was unable to perform self-MLD
at home due to arthritis and lack of home care assistance.
Because this patient required an additional home therapy
component but was at risk for exacerbating existing genital
lymphedema, in November 2007 she was prescribed the
FT system with trunk treatment rather than an IPC that
could treat only the limb. Her treatment protocol
consisted of one 60-minute treatment session for the
trunk and leg per day.
A single in-clinic session with FT resulted in a 4.4% decrease
in treated leg volume. By contrast, during a single in-clinic
session with the IPC device she had previously used, her
treated leg volume increased by 0.45% (Figure 2A).
During her long-term usage of FT, PT1 found the system to
be comfortable and easy to apply and remove without
assistance, and stated that it was relaxing enough that she
could fall asleep during a session. She described urinary
urgency occurring immediately after treatment with the FT
system, which may be indicative of effective lymphatic
drainage. She also stated that she had more stamina,
leading to a more active lifestyle, which she attributed to
the FT system. She proclaimed that she “could not live
without it.” At the time of this report, PT1 had used FT for
approximately one year; during that year she had no return
visits for CDT and experienced none of the complications
that had previously developed with use of older-genera-
tion IPC devices.
Case report 2
The second patient (PT2), a black female, was a 43-year-
old non-smoker with weight of 300 lbs and height of 6’2”
Figure 1.
Patient photographs: (A) Illustrating bilateral lower
extremity lymphedema greater on the left. (B) Patient 2,
showing right upper extremity lymphedema.
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at the time she presented for care at the clinic. She was
diagnosed in New York in 2000 with right upper extremity
lymphedema (Figure 1B) following treatment for breast
cancer in 1998 including mastectomy, axillary dissection
of 24 lymph nodes, radiation, and chemotherapy. A side
effect of the radiation was fibrosis of the lateral chest wall
and breast tissue. The patient’s first CDT began in 2002
after the lymphedema progressed with increased discom-
fort and recurrent infections. Between 2002 and 2006, she
had four episodes of cellulitis treated with multiple
antibiotics. She received three courses of intensive CDT,
including two to three visits weekly for three months. In
2004, she began using the programmable ProACT 1 pump
(Fore Tech Medical, Williamstown, NJ; HCPC code
E0652) intermittently for temporary relief of pain when
her symptoms were most bothersome. This device did not
provide treatment of her truncal lymphedema.
In 2006, she stopped using the ProACT 1 pump due to
development of a fibrotic cuff (at the limb root nearest the
axilla), skin irritation, and lack of sustained reduction of
lymphedema. She then moved to Georgia and in March
2007 began a fourth course of CDT, which required
treatment five days a week for four months. At the time she
began this treatment, arm volume measurements showed
that the affected arm had 31% greater volume than the
unaffected arm.
The patient’s self-MLD was not successful, because she was
unable to reach all affected areas and did not have anyone
at home to assist with her care. The FT system was
recommended because, in addition to treating her affected
arm, it treated the chest wall, trunk, and shoulder areas that
the patient could not reach. In December 2007, she began
using FT for in-home treatment. The treatment protocol
with the FT device consisted of one full upper-extremity
and chest treatment session per day. A single session with
the ProACT 1 pump produced a 2.9% increase in the
patient’s arm volume (Figure 2B). A session with FT was
associated with a 0.68% decrease in arm volume.
During her long-term experience with FT, PT2 reported the
device to be comfortable and easy to use without
assistance. She experienced softening of the fibrosis in
her arm, breast, and chest wall after incorporating the FT
system at home. The FT system also effectively treated
multiple affected areas, reducing edema in her fingers,
palm, forearm, upper arm, shoulder, and back. In
addition, with FT usage she did not develop a fibrotic
cuff or experience the skin irritation that had previously
occurred with usage of the older generation IPC.
Prior to treatment, PT2 received disability benefits due to
pain from the lymphedema and swelling. After treatment
with FT, she was able to return to work. She has not
required additional in-clinic CDT since initiating FT
therapy one year ago.
Discussion
It can be difficult for clinicians to identify effective ways to
help lymphedema patients successfully manage home
care. Risks associated with ineffective therapy include
worsening of the lymphedema, recurrent infections, pain,
and reduced range of motion [4, 8]. Daily treatment
regimens are physically and emotionally demanding, and
the patient’s quality of life is impaired by both the
lymphedema and the rigors of self-treatment [3, 9].
Recommended treatment should be both effective and
acceptable to the patient.
Both patients in this case series reported discomfort with
previously used IPC devices, neither of which provided
sustained management of lymphedema. Both had
Figure 2.
Lower volume measurements: (A) showing left lower
extremity volume measured before and after a single session
of treatment with Flexitouch and with the Extremity Pump
System 7500. (B) showing right upper extremity volume
measured before and after a single session of treatment with
Flexitouch and with the ProACT 1 system.
Measurements were made with a Juzo tape measure.
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required multiple intensive treatments for lymphedema
prior to being seen at Gwinnett Medical Center. Further-
more, these patients’ use of older-generation IPC devices
had resulted in complications, including worsening
genital edema (PT1) and development of a fibrotic cuff
(PT2). After incorporating long-term home usage of the
advanced FT device, both patients were able to successfully
control lymphedema without aggravating complications
they had previously experienced. Both patients achieved
successful home maintenance of lymphedema, as judged
by limb volume, clinical observations, and subjective
patient impressions, after incorporating the FT system.
The design features of the FT system may improve patient
outcomes and enhance acceptance and tolerance of the
device. The device uses a calibrated, work-and-release
inflation/deflation pattern applying therapeutic pressures
that are significantly different from those produced by
older-generation IPCs [10]. The FT system’s programma-
bility allows for focus on fibrotic areas and provides
treatment to the trunk and chest in addition to the affected
limb(s) [7], features that address concerns and limitations
expressed about older-generation IPC devices.
Conclusion
Incorporating the FT system as part of maintenance may
improve success for lymphedema patients who have
previously struggled with in-home management. Differ-
ences in design between the FT system and older-
generation IPC devices, as well as the unique means by
which the FT system provides truncal therapy, may
contribute to beneficial results and generate new interest
from therapists and patients in this advanced technology.
Patient’s Perspectives
Patient 1
I have lymphedema in both of my legs. Doing treatment at
home has been hard. I have arthritis, and I am unable to
put on compression garments myself or do self-massage,
because I can’t reach where I need to. I used an older pump
at home to treat my legs. That device was hard to get on
and it hurt, even on the lowest pressure setting. It did not
help with my fibrosis and in general, was not effective. The
Flexitouch is easy for me to get on and off without help. It
treats my legs and abdomen. It is soothing and relaxing
enough to fall asleep during treatment. The Flexitouch is
the most effective pump therapy I’ve had. I use it every day.
If I don’t use it, the swelling around my knees makes the
arthritis so painful that I can hardly walk. By using the
Flexitouch I am able to keep moving. I could not live
without it!
Patient 2
I got lymphedema after being treated for breast cancer. It
affected my arm as well as my chest. I am right-handed and
an accountant. Having lymphedema in my right arm
caused difficulty with typing and writing. It was painful.
I received in-clinic treatment for my lymphedema and was
trained to do treatments at home, such as lymphedema
massage. But I was not able to reach all affected areas, so
I did not see many results from my self-massage efforts.
I had tried a different pump in the past on a daily basis but
felt only temporary relief of some discomfort while it was
on. It did not last, and it had no effect onmy edema. It also
caused irritation at the zipper, and little sores developed.
My therapist recommended the Flexitouch, and I have
been using it for about a year. I am now able to treat
lymphedema onmy own. It is comfortable, treats all of my
chest and arm, and feels very much like my therapist’s
MLD technique. I am very much satisfied with the results
I have had using the Flexitouch system. The results have
been longer lasting.
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